Maze Therapeutics Inc. (MAZE) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Maze Therapeutics Inc.

    NASDAQ: MAZE · Real-Time Price · USD
    27.11
    0.61 (2.30%)
    At close: Oct 03, 2025, 3:59 PM
    27.11
    0.00%
    After-hours: Oct 03, 2025, 07:14 PM EDT

    Maze Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    PE Ratio
    		 13.37 -6.95 -6.07
    PEG Ratio
    		 -0.13 0.55 n/a
    PS Ratio
    		 4.17 n/a n/a
    PB Ratio
    		 -2.24 -1.87 -2.47
    P/FCF Ratio
    		 9.34 -8 -6.9
    P/OCF Ratio
    		 9.20 -8.04 -7.04
    OCF/S Ratio
    		 0.45 n/a n/a
    Debt / Equity Ratio
    		 -0.09 -0.13 -0.11
    Quick Ratio
    		 9.76 2.09 5.11
    Current Ratio
    		 9.76 2.09 5.11
    Asset Turnover
    		 0.70 n/a n/a
    Interest Coverage
    		 n/a n/a n/a
    Return on Equity
    		 -0.17 0.27 0.41
    Return on Assets
    		 0.22 -1.4 -0.77
    Return on Invested Capital
    		 0.25 -1.54 -0.81
    Dividend Yield
    		 n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a
    Gross Profit Margin
    		 1.00 n/a n/a
    Net Profit Margin
    		 0.31 n/a n/a
    Pretax Profit Margin
    		 0.32 n/a n/a
    Operating Profit Margin
    		 0.34 n/a n/a
    FCF Margin
    		 0.45 n/a n/a
    EBITDA Margin
    		 0.36 n/a n/a

    Add to Watchlist